The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
We are delighted with the improved trading performance of the Group. ASF had a major impact on our business in China during the first half of this financial year but I am pleased with the recovery in that territory and progress elsewhere. We look forward to releasing our results during September subject to the ability of our auditors to perform their tasks in the current working environment. The effect of COVID-19 on our staff, business, customers, and supply chains is being well managed and we are cautiously optimistic that our industry outlook will remain robust. Furthermore, and like most businesses, we are looking after our cash position."
beyond expectations
43.53 - 43.47
very interesting
46.87 - 47.01
Just bought today so obviously looking for some recovery here
18.89 - 20.70
down 15%
4.7 - 4.99
down 7.48%
As the economy returns to normal the prospects for Petards various projects will likewise be restored to good health in my estimation - and my opinion but dyor
The company expects to report revenue for 2019 of GBP15.8 million, down 21% from GBP20.0 million a year earlier, and down 8.7% compared to market expectations of GBP17.3 million.
Petards' order book at the end of December remained in the region of GBP15 million, it said, versus GBP19 million at the end of 2018.
"While it is disappointing to report on the lower than expected 2019 revenues due to customer re-scheduling and on the impact this and the higher project costs have had on profitability, the group remains in good shape," said Chair Raschid Abdullah.
He added: "Following the group's significant investment in recent years, and with little further investment in product development anticipated to be required in 2020, the group expects to be net cash generative in the coming year and the Board remains confident of the group's future prospects."
Petards Group plc, together with its subsidiaries, develops, supplies, and maintains technologies in advanced security, surveillance, and ruggedized electronic applications in the United Kingdom, Continental Europe, and internationally. It offers rail technology solutions, such as eyeTrain, a solution for digital on-train surveillance; and RTS, a solution that provides safety and efficiency of railways with crucial resource, asset, safety, and failure management software, as well as consultancy services. The company also provides traffic technologies that include ProVida mobile speed enforcement, a digital surveillance measurement with the police approved speed measurement tool; and Hawk ANPR, an automatic number plate recognition (ANPR) technology camera that manages access control, parking enforcement, level cross monitoring, traffic management, and law enforcement. In addition, it offers mobile ANPR solutions comprising tablet based mobile ANPR, PC boot mounted ANPR, and intelligent mobile camera ANPR; fixed site ANPR; and ANPR software solutions, such as management servers, software, and video evidence storages. Further, the company provides defense solutions and services, such as communication systems, advanced visual surveillance, in-service supports, defensive aide systems, control systems, and real threat stimulators, as well as consultancy services. It serves customers under eyeTrain, ProVida, and QRO brand names. Petards Group plc was incorporated in 1994 and is headquartered in Guildford, the United Kingdom.
7.6 - 8.275
still waiting for audited financials
Old/Wise - unfortunately coronavirus got in the way of any meaningful drilling this year.
Though the virus has not affected Mongolia much, yet borders were closed, and equipment and workers are back in China until everything opens up again and MB went to Singapore, so I would not expect PM to do much this year. Getting the Licence is key, and securing partners, if that is the way forward.
Had to pay 20,80p for my second purchase of the day,
Possible target 25p tomorrow?
20.066 - 20.8
moving on up
Expect to open higher Friday - imho
19.70 - 19.98
When are we expecting 45p
may I openly wonder?
Best day for ages @ MATD
Bones - what is your projection for VRE shares?
(sadly I jumped in without research)
Will research tonight
Bought a few @ 19.9
Looks like a good punt
but mostly heavily into MATD